Burleson Research Technologies (BRT) is a Contract Research Organization (CRO) in the Research Triangle Park area that provides laboratory services to clients from the biotechnology, pharmaceutical, chemical manufacturing, and health care industries with proof-of-concept, preclinical, clinical, and toxicology studies that reflect BRT staff scientific expertise. BRT was founded in 1996, performs Good Laboratory Practice (GLP) compliant studies, and has clients that span the globe. Countries represented include the United States, France, the U.K., Switzerland, Italy, Russia, Israel, New Zealand, Australia, Korea, Germany, and Japan. BRT provides flexibility in tailoring studies to best suit clients' individual requirements with accurate, confidential, and timely results utilizing quality assurance programs that guarantee adherence to these principles and GLP regulations.